Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phantom Limb | 3 | 2020 | 9 | 0.950 |
Why?
|
| Stroke | 4 | 2021 | 256 | 0.950 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 121 | 0.810 |
Why?
|
| Cerebral Hemorrhage | 4 | 2025 | 93 | 0.770 |
Why?
|
| Thrombolytic Therapy | 3 | 2025 | 39 | 0.670 |
Why?
|
| Fibrinolytic Agents | 3 | 2025 | 70 | 0.650 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 834 | 0.500 |
Why?
|
| Time-to-Treatment | 2 | 2025 | 29 | 0.460 |
Why?
|
| Retrospective Studies | 10 | 2025 | 2612 | 0.400 |
Why?
|
| Middle Aged | 13 | 2025 | 7310 | 0.340 |
Why?
|
| Motor Cortex | 2 | 2020 | 48 | 0.320 |
Why?
|
| Intracranial Hemorrhages | 3 | 2024 | 30 | 0.260 |
Why?
|
| Male | 13 | 2025 | 13771 | 0.250 |
Why?
|
| Gastrostomy | 1 | 2025 | 8 | 0.240 |
Why?
|
| Health Resources | 1 | 2025 | 19 | 0.240 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2025 | 5 | 0.240 |
Why?
|
| Humans | 16 | 2025 | 28581 | 0.230 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 4 | 0.220 |
Why?
|
| Palliative Care | 1 | 2025 | 84 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 100 | 0.220 |
Why?
|
| Disability Evaluation | 1 | 2024 | 54 | 0.220 |
Why?
|
| Aged | 8 | 2025 | 5525 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2024 | 122 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 224 | 0.210 |
Why?
|
| Female | 13 | 2025 | 15471 | 0.200 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 480 | 0.200 |
Why?
|
| Amputees | 2 | 2020 | 7 | 0.200 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 782 | 0.190 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 154 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 2045 | 0.190 |
Why?
|
| Time Factors | 5 | 2025 | 1600 | 0.190 |
Why?
|
| Telemedicine | 1 | 2025 | 187 | 0.180 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 32 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 265 | 0.170 |
Why?
|
| Cortical Excitability | 1 | 2020 | 2 | 0.170 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 17 | 0.170 |
Why?
|
| Gray Matter | 1 | 2020 | 24 | 0.170 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 37 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2020 | 46 | 0.160 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 26 | 0.160 |
Why?
|
| Functional Laterality | 1 | 2020 | 64 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 65 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 53 | 0.160 |
Why?
|
| Lower Extremity | 1 | 2020 | 85 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 87 | 0.150 |
Why?
|
| Aspirin | 1 | 2020 | 125 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 40 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 191 | 0.150 |
Why?
|
| Risk Factors | 4 | 2025 | 2111 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2025 | 2402 | 0.140 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2017 | 16 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 62 | 0.120 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 113 | 0.120 |
Why?
|
| Administration, Intravenous | 2 | 2024 | 30 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2024 | 36 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 988 | 0.110 |
Why?
|
| Adult | 5 | 2025 | 7922 | 0.100 |
Why?
|
| Length of Stay | 2 | 2025 | 240 | 0.100 |
Why?
|
| Recurrence | 2 | 2025 | 325 | 0.090 |
Why?
|
| United States | 2 | 2025 | 2201 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 421 | 0.070 |
Why?
|
| Perfusion Imaging | 1 | 2025 | 7 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2025 | 30 | 0.060 |
Why?
|
| Inpatients | 1 | 2025 | 60 | 0.060 |
Why?
|
| Illinois | 1 | 2024 | 3 | 0.060 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2024 | 2 | 0.060 |
Why?
|
| Rural Health Services | 1 | 2024 | 25 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2025 | 265 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2024 | 50 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 74 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2025 | 893 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 478 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 328 | 0.050 |
Why?
|
| Young Adult | 2 | 2020 | 2804 | 0.040 |
Why?
|
| Hematoma | 1 | 2020 | 26 | 0.040 |
Why?
|
| Chicago | 1 | 2020 | 6 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2020 | 7 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 14 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 22 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 51 | 0.040 |
Why?
|
| Amputation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 259 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 196 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 467 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2020 | 207 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 622 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 807 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 137 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 391 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 380 | 0.030 |
Why?
|